A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
Clinical trial NCT03744182 · COMPLETED
Trial details
- NCT number
- NCT03744182
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2020-03-18
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.